Actavis News
Most Popular Actavis Story
Actavis builder aims to pump up Alvogen
Remember Robert Wessman? The Icelandic businessman, who stepped down as CEO of Actavis about a year ago, is plotting a new assault on the generics business, using the U.S.-based Alvogen Group as a Read more...
Latest Headlines
- January 5, 2012
- December 22, 2011
- October 21, 2011
- June 23, 2011
- February 2, 2011
- December 13, 2010
- August 6, 2010
- July 22, 2010
- June 23, 2010
- March 17, 2010
- March 9, 2010
- March 4, 2010
- March 3, 2010
- February 18, 2010
- February 17, 2010
- February 11, 2010
- February 3, 2010
- November 12, 2009
- October 2, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
